Literature DB >> 31388124

Deglycosylated PD-L1 might be a better biomarker.

Peter Sidaway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31388124     DOI： 10.1038/s41571-019-0261-x

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  6 in total

Review 1.  Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy.

Authors:  Tao Wang; Desirée Denman; Silvia M Bacot; Gerald M Feldman
Journal:  Biomedicines       Date:  2022-05-20

Review 2.  Establishing peripheral PD-L1 as a prognostic marker in hepatocellular carcinoma patients: how long will it come true?

Authors:  D-W Sun; L An; H-Y Huang; X-D Sun; G-Y Lv
Journal:  Clin Transl Oncol       Date:  2020-05-27       Impact factor: 3.405

3.  Glycosylation of Siglec15 promotes immunoescape and tumor growth.

Authors:  Yun-Long Wang; Ming-Biao Wei; Wan-Wen Zhao; Li-Li Feng; Xin-Ke Yin; Shao-Mei Bai; Xiang-Bo Wan; Mien-Chie Hung; Andrew Z Zou; Michael H Wang; Jian Zheng; Caolitao Qin; Xin-Juan Fan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 4.  The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis.

Authors:  Ying-Nai Wang; Heng-Huan Lee; Jennifer L Hsu; Dihua Yu; Mien-Chie Hung
Journal:  J Biomed Sci       Date:  2020-07-03       Impact factor: 8.410

5.  A comparability study of natural and deglycosylated PD-L1 levels in lung cancer: evidence from immunohistochemical analysis.

Authors:  Jie Mei; Junying Xu; Xuejing Yang; Dingyi Gu; Weijian Zhou; Huiyu Wang; Chaoying Liu
Journal:  Mol Cancer       Date:  2021-01-07       Impact factor: 27.401

Review 6.  Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies.

Authors:  Alberto Puccini; Francesca Battaglin; Maria Laura Iaia; Heinz-Josef Lenz; Mohamed E Salem
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.